Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Arcos Dorados Holdings
ARCO
$1.66B
| $1.42M | ﹤0.01% |
+179,993
| New | +$1.3M |
|
2477
iShares MSCI Canada ETF
EWC
$6.56B
| $1.42M | ﹤0.01% |
47,400
-43,900
| -48% | -$1.28M |
|
2478
Camping World
CWH
$655M
| $1.41M | ﹤0.01% |
+95,800
| New | +$1.08M |
|
2479
Kewaunee Scientific
KEQU
$105M
| $1.41M | ﹤0.01% |
105,008
+4,311
| +4% | +$67.5K |
|
2480
SI-BONE Inc
SIBN
$850M
| $1.4M | ﹤0.01% |
65,300
+24,400
| +60% | +$438K |
|
2481
Tempest Therapeutics
TPST
$16.5M
| $1.4M | ﹤0.01% |
1,064
+32
| +3% | +$45.1K |
|
|
ALO
2482
DELISTED
Alio Gold Inc
ALO
| $1.4M | ﹤0.01% |
1,779,550
+113,761
| +7% | +$72.1K |
|
2483
Freedom Holding
FRHC
$9.4B
| $1.39M | ﹤0.01% |
+95,856
| New | +$1.36M |
|
2484
Esquire Financial Holdings
ESQ
$1.55B
| $1.39M | ﹤0.01% |
53,400
+33,500
| +168% | +$818K |
|
|
BSCL
2485
DELISTED
Invesco BulletShares 2021 Corporate Bond ETF
BSCL
| $1.39M | ﹤0.01% |
65,455
+50,155
| +328% | +$1.07M |
|
2486
Genasys
GNSS
$79.2M
| $1.39M | ﹤0.01% |
423,699
+7,538
| +2% | +$25.5K |
|
|
STXB
2487
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $1.38M | ﹤0.01% |
59,900
+14,300
| +31% | +$315K |
|
|
VVUS
2488
DELISTED
Vivus Inc
VVUS
| $1.38M | ﹤0.01% |
506,645
| – | – |
|
2489
Radcom
RDCM
$171M
| $1.37M | ﹤0.01% |
160,933
+8,200
| +5% | +$78.8K |
|
|
APTS
2490
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.36M | ﹤0.01% |
102,500
-84,800
| -45% | -$1.17M |
|
2491
Asbury Automotive
ABG
$3.76B
| $1.36M | ﹤0.01% |
+12,200
| New | +$1.31M |
|
|
FCBP
2492
DELISTED
First Choice Bancorp Common Stock
FCBP
| $1.36M | ﹤0.01% |
50,500
+9,500
| +23% | +$219K |
|
|
HWCC
2493
DELISTED
Houston Wire & Cable Company
HWCC
| $1.36M | ﹤0.01% |
308,352
+41,952
| +16% | +$172K |
|
2494
Educational Development Corp
EDUC
$11.8M
| $1.35M | ﹤0.01% |
219,324
+5,300
| +2% | +$34.5K |
|
2495
Schwab US Broad Market ETF
SCHB
$45.1B
| $1.35M | ﹤0.01% |
+105,480
| New | +$1.29M |
|
|
SACH
2496
Sachem Capital Corp
SACH
$38.2M
| $1.35M | ﹤0.01% |
310,900
+41,400
| +15% | +$185K |
|
|
PRSU
2497
Pursuit Attractions and Hospitality Inc
PRSU
$1.32B
| $1.34M | ﹤0.01% |
19,886
-64,314
| -76% | -$4.17M |
|
|
SBBP
2498
DELISTED
Strongbridge Biopharma plc.
SBBP
| $1.34M | ﹤0.01% |
641,600
+434,800
| +210% | +$834K |
|
|
ATSG
2499
DELISTED
Air Transport Services Group
ATSG
| $1.34M | ﹤0.01% |
57,100
-19,300
| -25% | -$433K |
|
2500
DLH Holdings
DLHC
$68.6M
| $1.34M | ﹤0.01% |
319,251
+3,281
| +1% | +$13.7K |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.